A Phase 3, multi-center, randomized, double-blind, placebo controlled study, to evaluate the safety and efficacy of SB-01 For Injection for the treatment of Lumbar Degenerative Disc Disease
Conquest Research needs volunteers for a lumbar degenerative disc disease trial evaluating a medication designed for the treatment of lumbar degenerative disc disease (LDDD) / chronic low back pain (CLBP). You may qualify if you:
Eligible participants will receive study-related care at no cost. Compensation for time and travel may be available. No medical insurance is required for participation.